Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fischer Medical Ventures has informed that the Board of Directors of the Company vide circular resolution passed on January 1, 2026, approved the reconstitution of Audit Committee, Nomination and Remuneration Committee, Risk Management Committee & Corporate Social Responsibility Committee of the Board of Directors, effective from the January 1st 2026.
The above information is a part of company’s filings submitted to BSE.
